ES2012118A6 - Procedimiento de obtencion de soluciones solidas de compuestos farmaceuticamente activos. - Google Patents

Procedimiento de obtencion de soluciones solidas de compuestos farmaceuticamente activos.

Info

Publication number
ES2012118A6
ES2012118A6 ES8802831A ES8802831A ES2012118A6 ES 2012118 A6 ES2012118 A6 ES 2012118A6 ES 8802831 A ES8802831 A ES 8802831A ES 8802831 A ES8802831 A ES 8802831A ES 2012118 A6 ES2012118 A6 ES 2012118A6
Authority
ES
Spain
Prior art keywords
pharmaceutically active
procedure
active compounds
solid solutions
obtaining solid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES8802831A
Other languages
English (en)
Inventor
Lorenz Hahn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES2012118A6 publication Critical patent/ES2012118A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE SOLUCIONES SOLIDAS DE COMPUESTOS FARMACEUTICAMENTE ACTIVOS, EN CONCRETO A BASE DE: A) UN COMPUESTO FARMACEUTICAMENTE ACTIVO, Y B) UN MONOESTER HIDROSOLUBLE DE UN ACIDO GRASO (C6-18) SATURADO O SIN SATURAR Y UN POLIOL, CARACTERIZADO PORQUE COMPRENDE: A) DISOLVER LOS COMPONENTES (A) Y (B) EN UN DISOLVENTE VOLATIL Y VOLATILIZAR EL DISOLVENTE; O B) LICUAR EL COMPONENTE (B) MEDIANTE FUSION, DISOLVER EL COMPONENTE (A) EN LA FUSION OBTENIDA Y SOLIDIFICAR LUEGO LA SOLUCION OBTENIDA POR ENFRIAMIENTO; Y C) RECUPERAR LA SOLUCION SOLIDA OBTENIDA.
ES8802831A 1987-09-15 1988-09-15 Procedimiento de obtencion de soluciones solidas de compuestos farmaceuticamente activos. Expired - Lifetime ES2012118A6 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3730909 1987-09-15
DE3802355 1988-01-27

Publications (1)

Publication Number Publication Date
ES2012118A6 true ES2012118A6 (es) 1990-03-01

Family

ID=25859774

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8802831A Expired - Lifetime ES2012118A6 (es) 1987-09-15 1988-09-15 Procedimiento de obtencion de soluciones solidas de compuestos farmaceuticamente activos.

Country Status (24)

Country Link
JP (1) JP3090666B2 (es)
KR (1) KR0131084B1 (es)
AT (1) AT395819B (es)
AU (1) AU628787B2 (es)
BE (1) BE1001204A5 (es)
CA (1) CA1338775C (es)
CH (1) CH683672A5 (es)
DK (1) DK175132B1 (es)
ES (1) ES2012118A6 (es)
FI (1) FI94837C (es)
FR (1) FR2620336B1 (es)
GB (1) GB2209671B (es)
GR (1) GR1002243B (es)
HU (1) HU205010B (es)
IE (1) IE61195B1 (es)
IL (1) IL87746A (es)
IT (1) IT1224886B (es)
LU (1) LU87335A1 (es)
MY (1) MY103769A (es)
NL (1) NL195094C (es)
NO (1) NO179434C (es)
NZ (1) NZ226163A (es)
PT (1) PT88492B (es)
SE (1) SE503279C2 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (ko) 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
GR1000466B (el) * 1989-01-28 1992-07-30 Sandoz Ag Μεθοδος παρασκευης νεων φαρμακευτικων μορφων κυκλοσπορινης.
CH679277A5 (es) * 1989-02-09 1992-01-31 Sandoz Ag
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
HK1004520A1 (en) 1992-05-13 1998-11-27 Novartis Ag Ophthalmic compositions containing a cyclosporin
PT589843E (pt) 1992-09-25 2002-04-29 Novartis Ag Composicoes farmaceuticas contendo ciclosporinas
ATE398448T1 (de) * 1993-09-28 2008-07-15 Scherer Gmbh R P Herstellung von weichgelatinekapseln
SK164796A3 (en) 1994-11-03 1997-06-04 Dresden Arzneimittel Novel cyclosporine preparation forms for oral administration of and process for producing them
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
TW414696B (en) * 1996-07-01 2000-12-11 Mitsubishi Kagaku Foods Kk Anti-bacteria agent
SK285019B6 (sk) 1997-01-30 2006-04-06 Novartis Ag Tvrdá želatínová tobolka
GB2326337A (en) * 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
EP1558215A4 (en) * 2003-10-14 2007-09-12 Wockhardt Ltd STERILE GELIFYING AGENTS
JP5422871B2 (ja) * 2006-10-24 2014-02-19 不二製油株式会社 イソフラボン類組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL284933A (es) * 1961-10-31
GB1134878A (en) * 1966-05-12 1968-11-27 Suga Kazuo Improvements in and relating to oryzanol solutions and compositions
FR5986M (es) * 1966-11-22 1968-06-21
BE787842A (fr) * 1971-08-25 1972-12-18 Sumito Chemical Cy Ltd Procede de preparation d'une suspension aqueuse de cristaux stables du type non beta d'esters d'acides gras superieurs du chloramphenicol
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
DE2907460A1 (de) * 1978-03-07 1979-09-13 Sandoz Ag Neue resorbierbare galenische kompositionen
JPS57128634A (en) * 1981-02-03 1982-08-10 Eisai Co Ltd Elastase-containing compound increasing absorption
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
JPS61280435A (ja) * 1985-04-04 1986-12-11 Kanji Takada サイクロスポリン類のリンパ指向性製剤

Also Published As

Publication number Publication date
FR2620336B1 (fr) 1991-10-25
CH683672A5 (de) 1994-04-29
KR890004694A (ko) 1989-05-09
KR0131084B1 (ko) 1998-04-17
NO884052L (no) 1989-03-16
DK511188A (da) 1989-03-16
FI94837B (fi) 1995-07-31
FI884192L (fi) 1989-03-16
SE8803221L (sv) 1989-03-16
NO179434C (no) 1996-10-09
SE503279C2 (sv) 1996-05-13
GB2209671A (en) 1989-05-24
NL8802275A (nl) 1989-04-03
PT88492B (pt) 1993-03-31
DK511188D0 (da) 1988-09-14
AT395819B (de) 1993-03-25
GR880100602A (el) 1989-06-22
IT1224886B (it) 1990-10-24
GR1002243B (en) 1996-04-22
MY103769A (en) 1993-09-30
AU2217288A (en) 1989-04-27
JP3090666B2 (ja) 2000-09-25
GB8821443D0 (en) 1988-10-12
PT88492A (pt) 1988-10-01
FI884192A0 (fi) 1988-09-13
FR2620336A1 (fr) 1989-03-17
JPH01151526A (ja) 1989-06-14
LU87335A1 (fr) 1989-04-06
HUT49494A (en) 1989-10-30
IL87746A0 (en) 1989-02-28
CA1338775C (en) 1996-12-10
DK175132B1 (da) 2004-06-14
IT8848349A0 (it) 1988-09-14
IE882772L (en) 1989-03-15
ATA224988A (de) 1992-08-15
IE61195B1 (en) 1994-10-19
AU628787B2 (en) 1992-09-24
NO179434B (no) 1996-07-01
NL195094C (nl) 2003-12-17
SE8803221D0 (sv) 1988-09-13
GB2209671B (en) 1991-11-13
FI94837C (fi) 1995-11-10
IL87746A (en) 1992-07-15
NO884052D0 (no) 1988-09-13
HU205010B (en) 1992-03-30
NZ226163A (en) 1991-08-27
BE1001204A5 (fr) 1989-08-16

Similar Documents

Publication Publication Date Title
ES2012118A6 (es) Procedimiento de obtencion de soluciones solidas de compuestos farmaceuticamente activos.
GB2249956B (en) Transdermal device with dual solvent for active ingredient
DK162019C (da) Fremgangsmaade til fremstilling af orale praeparatformer indeholdende antidiabetica og orale praeparatformer indeholdende antidiabetica
ES8308698A1 (es) Procedimiento para preparar una composicion penetrable por la piel a base de agentes terapeuticos sistematicamente activos
AR241226A1 (es) 3-(2,2-difluorbenzodioxol-4-il)-4-cianopirrol procedimiento para su preparacion, intermediario y composion microbicida que contiene dicho compuesto.
ES479102A1 (es) Procedimiento para preparar una composicion catalitica a ba-se de titanio y magnesio.
DK0460185T3 (da) Fremstilling af farmaceutiske og andre matrixsystemer ved opløsning i fast tilstand
GB2314508A (en) Diamide-dicarboxylic acid microspheres
NO801983L (no) Fremgangsmaate for behandling av blandinger av oksyder av sjeldne jordartmetaller og gallium
DE69112914D1 (de) Herstellungsverfahren von Mikrokugeln.
DK1061948T3 (da) Præparat til vedvarende frigivelse af et fysiologisk aktivt polypeptid samt fremstilling deraf
ES2076190T3 (es) Uso de fluor que contiene derivados del acido piridona-carboxilico para la preparacion de un medicamento para el tratamiento de las infecciones causadas por hiv.
DK159590C (da) Fremgangsmaade til forhindring af nedbrydning af thieno-pyridinderivater
DK148744C (da) Analogifremgangsmaade til fremstilling af den enkelte isomere eller en isomerblanding af spiro-(1,3-dioxolan-4,3') quinuclidiner eller farmaceutisk acceptable syreadditionssalte deraf
AT365926B (de) Verfahren zum stabilisieren von pharmakologisch aktiven prostacyclinverbindungen
JPS52127085A (en) Semiconductor laser
JPS52109545A (en) Preparation of aqueous polyolefin dispersions
JPS5437594A (en) Semiconductor laser and its manufacture
BR7605087A (pt) Processo para a preparacao de esteres de acido(tiono)(tiol)piridazinonalcanofosfonico,e composicoes inseticidas e acaricidas a base destes
JPS51113839A (en) Process for obtaining optically active phenylglycine
JPS5225574A (en) Production method of semiconsuctor device
DK145906C (da) Analogifremgangsmaade til fremstilling af n,n-dimethyl-trans-2-(m-halogenphenyl)bicyclo(2,2,2)oct-3-yl-methylamin og syreadditionssalte deraf
JPS51119793A (en) A method for preparing poly-p-phenylene terephthalamide solutions
JPS51133426A (en) A method for detecting activities of insecticides
AR241714A1 (es) Procedimiento para preparar derivados de 5-vinil-2-pirrolidinona y preparacion de aminoacidos olefinicos.

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2008-09-15

PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20080916